Design and biological evaluation of novel biphenyl-dihydropyrimidinone derivatives with selective anticancer and nongenotoxic profiles
Biochemistry and Cell Biology · 01.01.2026 · 104 · 1-22
DOI: 10.1139/bcb-2025-0370 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry and Cell Biology, erschienen am 01.01.2026. Verfasst von Mehmet Fidan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Science and Art Center, The Ministry of National Education, 19100 Çorum, Türkiye. Hauptthemen laut MEDLINE: Antineoplastic Agents, Pyrimidinones, Biphenyl Compounds, Drug Design. Die Arbeit nennt 90 Literaturangaben. Gefördert von: Amasya Üniversitesi.
Abstract (Originalsprache)
This study reports the p-toluenesulfonic acid-catalyzed synthesis of three novel 3,4-dihydropyrimidin-2(1H)-one derivatives (4a = PMe, 4b = PPh, 4c = PNO 2 ) based on a 1,1′-biphenyl, and the evaluation of their cytotoxic, genotoxic, antioxidant, and apoptosis-related effects in vitro and in vivo. Structural characterization was performed using FT-IR, 1 H NMR, APT- 13 C NMR, and LC/MS-MS. Cytotoxicity was assessed on A549 human lung cancer and MRC-5 normal lung fibroblast cells using the WST-8 assay, while genotoxicity was evaluated using the Drosophila wing SMART assay. qRT-PCR was conducted to analyze gene expression related to cellular stress responses, antioxidant defense, and apoptosis in both cell lines and Drosophila melanogaster. All compounds exhibited dose-dependent cytotoxicity toward A549 cells with low toxicity in MRC-5 cells, indicating selective anticancer activity. Compound 4b showed the strongest cytotoxic effect (highest potency), whereas compound 4c exhibited the highest selectivity index (SI = 1.22), indicating a more favorable therapeutic window. Compound 4a induced a pro-apoptotic shift in the BAX/BCL-2 ratio, and all compounds enhanced antioxidant gene expression, particularly 4a. No significant genotoxic effects were detected. These findings suggest that the synthesized dihydropyrimidinone derivatives possess selective anticancer potential and favorable genotoxic safety profile, with mechanistic diversity supporting their relevance for targeted cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Science and Art Center, The Ministry of National Education, 19100 Çorum, Türkiye.
- Department of Medical Services and Techniques, Sabuncuoglu Serefeddin Health Services Vocational School, Amasya University, 05100 Amasya, Türkiye.
- Department of Chemistry, Faculty of Science and Arts, Ordu University, 52200 Ordu, Türkiye.
- Project Coordination and Guidance Office, Rectorate, Hitit University, 19100 Çorum, Türkiye.
- Department of Biotechnology, Institute of Science, Amasya University, 05100 Amasya, Türkiye.
ORCID-Profile: Arif Ayar
Förderung
- Amasya Üniversitesi
Zitieren
APA
Fidan, M., Ayar, A., Ertürk, A., Mesci, S., Yazgan, B., & Yıldırım, T. (2026). Design and biological evaluation of novel biphenyl-dihydropyrimidinone derivatives with selective anticancer and nongenotoxic profiles. Biochemistry and Cell Biology, 104, 1-22. https://doi.org/10.1139/bcb-2025-0370
Vancouver
Fidan M, Ayar A, Ertürk A, Mesci S, Yazgan B, Yıldırım T. Design and biological evaluation of novel biphenyl-dihydropyrimidinone derivatives with selective anticancer and nongenotoxic profiles. Biochemistry and Cell Biology. 2026;104:1-22. doi:10.1139/bcb-2025-0370
BibTeX
@article{Fidan2026,
author = {Fidan, Mehmet and Ayar, Arif and Ertürk, Aliye Gediz and Mesci, Seda and Yazgan, Burak and Yıldırım, Tuba},
title = {Design and biological evaluation of novel biphenyl-dihydropyrimidinone derivatives with selective anticancer and nongenotoxic profiles},
journal = {Biochemistry and Cell Biology},
year = {2026},
volume = {104},
pages = {1--22},
doi = {10.1139/bcb-2025-0370}
}
EUVIMED